[A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
Shparyk
Ia V
IaV
Kravets
A I
AI
Bilyns'kyĭ
B T
BT
Kuftiak
O F
OF
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000532:radiotherapy*; D011379:Prognosis; D012074:Remission Induction
D000964:Antimetabolites, Antineoplastic; D002945:Cisplatin; D005472:Fluorouracil